103 related articles for article (PubMed ID: 6532541)
21. The use of neoadjuvant CMF to avoid mastectomy.
George ML; Hale PC; Gumpert JR; Hogbin BM; Deutsch GP; Yelland A
Eur J Surg Oncol; 1999 Feb; 25(1):50-3. PubMed ID: 10188855
[TBL] [Abstract][Full Text] [Related]
22. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
[TBL] [Abstract][Full Text] [Related]
24. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
Viens P; Palangié T; Janvier M; Fabbro M; Roché H; Delozier T; Labat JP; Linassier C; Audhuy B; Feuilhade F; Costa B; Delva R; Cure H; Rousseau F; Guillot A; Mousseau M; Ferrero JM; Bardou VJ; Jacquemier J; Pouillart P
Br J Cancer; 1999 Oct; 81(3):449-56. PubMed ID: 10507769
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
Veyret C; Levy C; Chollet P; Merrouche Y; Roche H; Kerbrat P; Fumoleau P; Fargeot P; Clavere P; Chevallier B
Cancer; 2006 Dec; 107(11):2535-44. PubMed ID: 17054108
[TBL] [Abstract][Full Text] [Related]
28. [Inflammatory cancer of the breast. Study of 4 cases in prolonged remission].
Sans-Sabrafen J; Besses Raebel C
Med Clin (Barc); 1986 Feb; 86(4):155-7. PubMed ID: 3702516
[No Abstract] [Full Text] [Related]
29. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
Sidorova NA; Volchenko NN; Saribekian EK
Sov Med; 1991; (11):15-8. PubMed ID: 1662831
[TBL] [Abstract][Full Text] [Related]
30. [The therapy of advanced breast carcinoma in men].
Renziehausen L; Quietzsch D
Dtsch Med Wochenschr; 1992 Jan; 117(5):172-6. PubMed ID: 1735376
[TBL] [Abstract][Full Text] [Related]
31. Multimodal treatment for inflammatory breast cancer.
Thoms WW; McNeese MD; Fletcher GH; Buzdar AU; Singletary SE; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):739-45. PubMed ID: 2487034
[TBL] [Abstract][Full Text] [Related]
32. [Improvement of survival due to adjuvant therapy in patients with operable breast carcinoma].
Repelaer van Driel OJ; Welvaart K; Stijnen T
Ned Tijdschr Geneeskd; 1986 Apr; 130(16):744-6. PubMed ID: 3713882
[No Abstract] [Full Text] [Related]
33. [Therapy of bone metastases in breast cancer].
Köhler AH; Dobberstein N; Stoltmann R; Heschel U
Zentralbl Chir; 1984; 109(7):483-9. PubMed ID: 6203258
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast.
Elias EG; Vachon DA; Didolkar MS; Aisner J
Am J Surg; 1991 Sep; 162(3):231-5. PubMed ID: 1656805
[TBL] [Abstract][Full Text] [Related]
35. The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients.
Chevallier B; Bastit P; Graic Y; Menard JF; Dauce JP; Julien JP; Clavier B; Kunlin A; D'Anjou J
Br J Cancer; 1993 Mar; 67(3):594-601. PubMed ID: 8439510
[TBL] [Abstract][Full Text] [Related]
36. [Adjuvant therapy following breast-sparing surgery of breast carcinoma: priority to chemo- or radiotherapy?].
Goldhirsch A; Castiglione-Gertsch M; Neuenschwander H
Ther Umsch; 1988 Jun; 45(6):383-8. PubMed ID: 3046036
[No Abstract] [Full Text] [Related]
37. [Breast cancer with cerebral metastases: complete remission for 5 years].
Sans-Sabrafen J; Besses Raebel C; Pardo Peret P
Med Clin (Barc); 1984 Nov; 83(17):721-2. PubMed ID: 6097778
[No Abstract] [Full Text] [Related]
38. Effect of preoperative rescue concomitant FUN/XUN-based chemo-radiotherapy for neoadjuvant chemotherapy-refractory breast cancer.
Bourgier C; Ghorbel I; Heymann S; Barhi M; Mazouni C; Al Ghuzlan AA; Balleyguier C; Marsiglia H; Delaloge S
Radiother Oncol; 2012 May; 103(2):151-4. PubMed ID: 22402230
[TBL] [Abstract][Full Text] [Related]
39. Secondary inflammatory breast cancer: treatment options.
Henderson MA; McBride CM
South Med J; 1988 Dec; 81(12):1512-7. PubMed ID: 3201299
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer in a male. Report of a case].
Caballero JL; Ríos B
Rev Med Panama; 1992 Jan; 17(1):57-60. PubMed ID: 1603988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
